๐ฐ Scope Group News
Page 2 - Scope Group News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Scope Group. Real-time updates on events, politics, business and more.
June 17, 2024
Working to shut down what could be possibly be a much wider Terror Network behind the attack. They raided locations and manchester wednesday carrying out controlled explosions in some cases, we believe to open up doorways and gain access. The 22yearold suspect who blew him up monday night authority says probably did not act alone and that is worrying. He had just returned to the uk after spending three weeks in libya. Now, the New York Times has publish photos claiming to show the aftermath of t...
January 17, 2024
The demolition of a dangerous and dilapidated building in Princes St is nearly complete. After a short delay, Scope Group began the demolition in...
December 18, 2023
A digger makes progress demolishing the derelict Princes St and Stafford St buildings in Dunedin yesterday. The demolition which began in September...
December 7, 2023
Demolition of derelict buildings in Princes and Stafford Sts in Dunedin will take a little longer than expected, as some of the work is carried out...
November 1, 2023
Part of Princes St in central Dunedin has been closed to traffic after a facade collapsed during the demolition of four derelict buildings. A...
November 1, 2023
Demolition work was paused at derelict Princes St buildings yesterday after a facade collapsed, leaving a portion of the building unstable. A...
October 19, 2023
The delayed demolition of four dangerous, dilapidated central Dunedin buildings is about to begin, the buildingsโ owner says.
September 22, 2023
The demolition of a group of derelict buildings in central Dunedin has been delayed due to "unanticipated administrative issues". Originally...
September 19, 2023
Demolition of derelict buildings in Princes St, Dunedin, is set to start on Monday next week. Buildingsโ owners urged to โget on with itโ The work...
June 14, 2023
Drug companies like BMS, GSK and Amgen face revenue losses from patent expirations